Gastritis News and Research

RSS
Gastritis is not a single disease, but several different conditions that all have inflammation of the stomach lining. Gastritis can be caused by drinking too much alcohol, prolonged use of nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin or ibuprofen, or infection with bacteria such as Helicobacter pylori (H. pylori). Sometimes gastritis develops after major surgery, traumatic injury, burns, or severe infections. Certain diseases, such as pernicious anemia, autoimmune disorders, and chronic bile reflux, can cause gastritis as well.
Cholestenone could be a new antibacterial drug against H. pylori

Cholestenone could be a new antibacterial drug against H. pylori

Study finds a bacterial molecule that may be key to fighting gastric cancer

Study finds a bacterial molecule that may be key to fighting gastric cancer

RedHill provides opaganib treatment under compassionate use exemption for Swiss COVID-19 patients

RedHill provides opaganib treatment under compassionate use exemption for Swiss COVID-19 patients

A new method to determine how carcinogenic bacteria reach their targets

A new method to determine how carcinogenic bacteria reach their targets

Regular walnut intake may help protect against negative outcomes associated with H. pylori infection

Regular walnut intake may help protect against negative outcomes associated with H. pylori infection

DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19

DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19

RedHill Biopharma: RHB-204 receives FDA Fast Track designation for treatment of NTM disease

RedHill Biopharma: RHB-204 receives FDA Fast Track designation for treatment of NTM disease

P2 COVID-19 study shows no material safety differences between opaganib and control arms

P2 COVID-19 study shows no material safety differences between opaganib and control arms

Phase 2/3 COVID-19 study evaluates safety, potential identification of preliminary efficacy signals

Phase 2/3 COVID-19 study evaluates safety, potential identification of preliminary efficacy signals

RedHill Biopharma announces promising preliminary results from opaganib study

RedHill Biopharma announces promising preliminary results from opaganib study

Food products are potential SARS-CoV-2 carriers, study finds

Food products are potential SARS-CoV-2 carriers, study finds

New guideline for juvenile idiopathic arthritis gives emphasis to disease-modifying treatments

New guideline for juvenile idiopathic arthritis gives emphasis to disease-modifying treatments

Daily cranberry intake could reduce H. pylori infections

Daily cranberry intake could reduce H. pylori infections

Study shows global prevalence of functional gastrointestinal disorders

Study shows global prevalence of functional gastrointestinal disorders

Study shows how long-term use of acid suppressants could increase risk of dementia

Study shows how long-term use of acid suppressants could increase risk of dementia

Treating hospitalized COVID-19 patients with anticoagulants may improve their survival chances

Treating hospitalized COVID-19 patients with anticoagulants may improve their survival chances

AGA publishes clinical guideline for managing patients with gastric intestinal metaplasia

AGA publishes clinical guideline for managing patients with gastric intestinal metaplasia

Antibiotic resistance doubles in just two decades

Antibiotic resistance doubles in just two decades

Cincinnati Children's receives NIH grant renewal for collaborative research into eosinophilic disorders

Cincinnati Children's receives NIH grant renewal for collaborative research into eosinophilic disorders

Japanese researchers explain how inflammation causes gastric tumors

Japanese researchers explain how inflammation causes gastric tumors